In addition, a meta-analysis of 11 studies among 36,452 cases and 39,781 controls is also performed to evaluate the contribution of rs4977574 of CDKN2BAS gene to the risk of CHD. This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.